Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Pharm Biomed Anal ; 51(5): 1047-53, 2010 Apr 06.
Artigo em Inglês | MEDLINE | ID: mdl-20018474

RESUMO

A novel inhibitor of reverse transcriptase was studied by solid-state NMR. Three phases of the compound were examined which included the dihydrate and two anhydrous polymorphs (Form I and Form III). By correlating (1)H and (13)C solution NMR with the solid-state (13)C NMR CP/MAS and CPPI spectral editing experiments, comparative (13)C assignments were made for each phase. Polymorphs of Form I and Form III and the dihydrate were easily distinguished based upon chemical shift patterns of the carbon resonances. The (1)H spin-lattice relaxation times were also measured for each phase which provided information on the mobility and relative crystallinity. The (13)C ssNMR spectrum of Form I showed the presence of a minor component identified as the dihydrate. Weight/percent quantitation of major and minor components in Form I was obtained from integrated intensities of a 50:50 mixture containing weighed amounts of Form I and the pure dihydrate. Comparison of the ssNMR and X-ray powder diffraction techniques is discussed.


Assuntos
Azepinas/química , Espectroscopia de Ressonância Magnética , Piridinas/química , Inibidores da Transcriptase Reversa/química , Tecnologia Farmacêutica/métodos , Cristalização , Cristalografia por Raios X , Estrutura Molecular , Difração de Pó , Água/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...